These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15946780)

  • 1. New drug targets in the signaling pathways activated by antidepressants.
    Páez-Pereda M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1010-6. PubMed ID: 15946780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurobiological mechanisms of depression and antidepressant therapy].
    Shishkina GT; Dygalo NN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From monoamines to genomic targets: a paradigm shift for drug discovery in depression.
    Wong ML; Licinio J
    Nat Rev Drug Discov; 2004 Feb; 3(2):136-51. PubMed ID: 15040578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-elicited changes in gene expression: remodeling of neuronal circuits as a new hypothesis for drug efficacy.
    Yamada M; Yamada M; Higuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):999-1009. PubMed ID: 15975701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRH signaling. Molecular specificity for drug targeting in the CNS.
    Refojo D; Holsboer F
    Ann N Y Acad Sci; 2009 Oct; 1179():106-19. PubMed ID: 19906235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in depression and antidepressants.
    Bondy B
    Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular mechanisms of antidepressant drug action.
    Shelton RC
    Harv Rev Psychiatry; 2000 Oct; 8(4):161-74. PubMed ID: 11038341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the molecular treatment of depression].
    Páez X; Hernández L; Baptista T
    Rev Neurol; 2003 Sep 1-15; 37(5):459-70. PubMed ID: 14533097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis in drug discovery: an uplifting view of depression.
    Levy SE
    Sci STKE; 2003 Oct; 2003(206):pe46. PubMed ID: 14583588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
    Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
    Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
    Tardito D; Perez J; Tiraboschi E; Musazzi L; Racagni G; Popoli M
    Pharmacol Rev; 2006 Mar; 58(1):115-34. PubMed ID: 16507885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenomics and future antidepressant research].
    Yamada M
    Seishin Shinkeigaku Zasshi; 2002; 104(10):810-8. PubMed ID: 12607922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to antidepressant drug discovery: beyond monoamines.
    Berton O; Nestler EJ
    Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulators of G-protein-coupled receptor-G-protein coupling: antidepressants mechanism of action.
    Schreiber G; Avissar S
    Expert Rev Neurother; 2007 Jan; 7(1):75-84. PubMed ID: 17187499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant action: to the nucleus and beyond.
    Malberg JE; Blendy JA
    Trends Pharmacol Sci; 2005 Dec; 26(12):631-8. PubMed ID: 16246434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.